Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 11169
Gene Symbol: WDHD1
WDHD1
0.010 Biomarker disease BEFREE Cohort study of Iraq and Afghanistan veterans in VHA (N = 181,620) with a PTSD diagnosis and ≥1 psychotherapy-coded outpatient visit from 2001 to 2014. 31850650 2019
Entrez Id: 285
Gene Symbol: ANGPT2
ANGPT2
0.010 Biomarker disease BEFREE The present study investigated whether angiotensin (Ang) II-elicited hypertensive response is sensitized in a model of PTSD and whether inhibition of angiotensin-converting enzyme (ACE) or tumor necrosis factor (TNF)-α prior to PTSD blocks this sensitization of Ang II hypertension. 31063551 2019
Entrez Id: 2108
Gene Symbol: ETFA
ETFA
0.010 Biomarker disease BEFREE MDMA therapy for PTSD is now entering the final Phase 3 stage of drug development, with a target set for licensing by the FDA and EMA in 2021. 30949077 2019
Entrez Id: 4776
Gene Symbol: NFATC4
NFATC4
0.010 Biomarker disease BEFREE Our results show that CaN/NFATc4 pathway were involved in the development of PTSD model, which suggested that the changes of CaN/NFATc4 pathway may be one of the pathological molecular mechanism in the dysfunction of hippocampus in PTSD. 31486013 2019
Entrez Id: 54819
Gene Symbol: ZCCHC10
ZCCHC10
0.010 AlteredExpression disease BEFREE Ten genes (C5orf24, RBAK, CREBZF, CD69, PMAIP1, AGL, ZNF644, ANKRD13C, ESCO1, and ZCCHC10) were upregulated in participants with PTSD and high intrusion symptoms at baseline and downregulated in participants with improved PTSD symptoms following treatment. 31039430 2019
Entrez Id: 3061
Gene Symbol: HCRTR1
HCRTR1
0.010 GeneticVariation disease BEFREE However, a significant interaction effect between GHRL rs696217 and HCRTR1 rs2271933 was found to predict the PTSD Checklist (PCL-5) total score (P =  0.007). 30326460 2019
Entrez Id: 3600
Gene Symbol: IL15
IL15
0.010 GeneticVariation disease BEFREE We discover, but do not replicate, one region, 4q31, close to the IL15 gene, which is genome-wide significantly associated with PTSD. 30999091 2019
Entrez Id: 4233
Gene Symbol: MET
MET
0.010 Biomarker disease BEFREE 183 veterans with DSM-IV PTSD and SUD at two VA Medical Centers were randomized to one of two psychotherapies during which Motivational Enhancement Therapy [MET] for SUD and Prolonged Exposure [PE] for PTSD were either phased or integrated throughout treatment. 31675546 2019
Entrez Id: 3107
Gene Symbol: HLA-C
HLA-C
0.010 Biomarker disease BEFREE HLA-B*58:01 (p = 0.035), HLA-C*07:01 (p = 0.035), HLA-DQA1*01:01 (p = 0.003), HLA-DQB1*05:01 (p = 0.009) and HLA-DPB1*17:01 (p = 0.017) were more common in PTSD cases, while HLA-A*02:01 (p = 0.026), HLA-DQA1*05:05 (p = 0.011) and HLA-DRB1*11:01 (p < 0.001) were more frequent in controls. 31310798 2019
Entrez Id: 2254
Gene Symbol: FGF9
FGF9
0.010 GeneticVariation disease BEFREE The primary outcome measure was severity of PTSD-symptoms (Harvard Trauma Questionnaire (HTQ)) and secondary outcome measures were depression and anxiety symptoms (Hopkins Symptom Checklist-25 (HSCL-25), Hamilton Depression and Anxiety rating scales (HAM-D, HAM-A)), somatisation (somatisation items of SCL-90 (SI-SCL-90)), quality of life (WHO-5-Well-being Index (WHO-5)) and functioning (Sheehan Disability Scale (SDS), Global Assessment of Functioning (GAF-F, GAF-S)). 30791342 2019
Entrez Id: 3106
Gene Symbol: HLA-B
HLA-B
0.010 Biomarker disease BEFREE HLA-B*58:01 (p = 0.035), HLA-C*07:01 (p = 0.035), HLA-DQA1*01:01 (p = 0.003), HLA-DQB1*05:01 (p = 0.009) and HLA-DPB1*17:01 (p = 0.017) were more common in PTSD cases, while HLA-A*02:01 (p = 0.026), HLA-DQA1*05:05 (p = 0.011) and HLA-DRB1*11:01 (p < 0.001) were more frequent in controls. 31310798 2019
Entrez Id: 4155
Gene Symbol: MBP
MBP
0.010 GeneticVariation disease BEFREE However, the results of MBP rs12458282 within the patients with lifetime PTSD may point to a possible correlation of the major allele (T) with elevated CAPS scores. 31291231 2019
Entrez Id: 104355217
Gene Symbol: ERICD
ERICD
0.010 Biomarker disease BEFREE We conducted systematic searches in five databases (Medline, Embase, PyscINFO, CINAHL, ERIC, Sociological Abstracts) from database inception to October 17, 2017 using index terms and keywords for CSA, disclosure, and PTSD. 30999168 2019
Entrez Id: 1776
Gene Symbol: DNASE1L3
DNASE1L3
0.010 Biomarker disease BEFREE This study aimed to assess and compare drug use patterns and the presence of childhood sexual abuse (CSA) experiences among ecstasy and LSD users with and without Posttraumatic Stress Disorder (PTSD). 31020892 2019
Entrez Id: 4184
Gene Symbol: SMCP
SMCP
0.010 GeneticVariation disease BEFREE Controlling for other factors, having PTSD symptoms after 9/11 predicted a nearly 10-point difference in mean MCS-12 compared with never having PTSD. 30909548 2019
Entrez Id: 345643
Gene Symbol: MCIDAS
MCIDAS
0.010 Biomarker disease BEFREE Mostly as a complementary treatment, however, for some disorders already with a 1a evidence level, e.g., depression, dementia or MCI but also post-traumatic stress disorder. 29564546 2019
Entrez Id: 3358
Gene Symbol: HTR2C
HTR2C
0.010 Biomarker disease BEFREE Increased 5-HT2C receptor editing predisposes to PTSD-like behaviors and alters BDNF and cytokines signaling. 30792491 2019
Entrez Id: 693183
Gene Symbol: MIR598
MIR598
0.010 GeneticVariation disease BEFREE Given that stress is a critical component in PTSD, we next assessed the impact of stress and stress-enhanced fear learning (SEFL) on mir-598-3p levels, finding the miRNA is elevated in the BLA of male, but not female, mice susceptible to the effects of stress in SEFL. 31416909 2019
Entrez Id: 7089
Gene Symbol: TLE2
TLE2
0.010 Biomarker disease BEFREE In summary, GRg2 alleviated the PTSD-associated behavioral deficits with biosynthesis of neurosteroids, normalization of serotonergic system and HPA axis dysfunction. 31103345 2019
Entrez Id: 4878
Gene Symbol: NPPA
NPPA
0.010 Biomarker disease BEFREE Over half of the participants had a formal diagnosis of post-traumatic stress disorder (PTSD) and/or PND related to the previous birth. 30740076 2019
Entrez Id: 7161
Gene Symbol: TP73
TP73
0.010 PosttranslationalModification disease BEFREE Successful treatment of PTSD was accompanied by significant changes in DNA methylation at 12 differentially methylated regions (DMRs) in the genes: APOB, MUC4, EDN2, ZFP57, GPX6, CFAP45, AFF3, TP73, UBCLP1, RPL13P, and two intergenic regions (p values < 0.0001 were confirmed using permutation and sensitivity analyses). 31645664 2019
Entrez Id: 3162
Gene Symbol: HMOX1
HMOX1
0.010 AlteredExpression disease BEFREE In contrast, Keap1 knockdown increased the expression of HO-1, improved hippocampal neurogenesis, and alleviated PTSD-like behaviors. 31293390 2019
Entrez Id: 6418
Gene Symbol: SET
SET
0.010 Biomarker disease BEFREE SET-Q total score was positively correlated with HTQ Part IV Post-Traumatic Stress Disorder (PTSD) and Self-Perception of Functioning scales (SPFS) while the number of stressful experiences with the local population was positively related to BDI-II depression symptoms. 31164967 2019
Entrez Id: 7072
Gene Symbol: TIA1
TIA1
0.010 Biomarker disease BEFREE Our results uncover a physiological and partly sex-dependent function for TIA1 in fear memory and may provide molecular insight into stress-related psychiatric conditions, such as post-traumatic stress disorder (PTSD) and anxiety. 30865887 2019
Entrez Id: 2693
Gene Symbol: GHSR
GHSR
0.010 GeneticVariation disease BEFREE However, the students with PTSD had significantly lower levels of glucose, insulin and homeostasis model assessment of insulin resistance (HOMA-IR) than the students without PTSD in the C allele carriers of GHSR rs495225 after the adjustment for age, gender and body mass index (BMI), but higher levels of TG and TG/HDL-C in the TT homozygotes. 30269201 2019